Integrated Wealth Concepts’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.9M | Buy |
78,969
+17,021
| +27% | +$3.66M | 0.1% | 200 |
|
|
2026
Q1 | $13.5M | Buy |
61,948
+27,635
| +81% | +$6.13M | 0.11% | 195 |
|
|
2025
Q4 | $7.84M | Sell |
34,313
-25,750
| -43% | -$5.87M | 0.09% | 197 |
|
|
2025
Q3 | $13.9M | Buy |
60,063
+4,643
| +8% | +$945K | 0.12% | 154 |
|
|
2025
Q2 | $10.3M | Sell |
55,420
-2,798
| -5% | -$520K | 0.1% | 183 |
|
|
2025
Q1 | $12.2M | Buy |
58,218
+3,659
| +7% | +$711K | 0.14% | 147 |
|
|
2024
Q4 | $9.7M | Buy |
54,559
+2,996
| +6% | +$551K | 0.11% | 174 |
|
|
2024
Q3 | $10.2M | Sell |
51,563
-1,390
| -3% | -$259K | 0.12% | 164 |
|
|
2024
Q2 | $9.08M | Buy |
52,953
+1,237
| +2% | +$205K | 0.12% | 169 |
|
|
2024
Q1 | $9.42M | Buy |
51,716
+1,905
| +4% | +$328K | 0.14% | 165 |
|
|
2023
Q4 | $7.72M | Sell |
49,811
-5,023
| -9% | -$732K | 0.13% | 181 |
|
|
2023
Q3 | $8.17M | Sell |
54,834
-3,257
| -6% | -$478K | 0.14% | 161 |
|
|
2023
Q2 | $7.83M | Buy |
58,091
+253
| +0.4% | +$37.1K | 0.13% | 167 |
|
|
2023
Q1 | $9.22M | Buy |
57,838
+23,978
| +71% | +$3.67M | 0.19% | 124 |
|
|
2022
Q4 | $5.47M | Buy |
33,860
+452
| +1% | +$69.3K | 0.15% | 143 |
|
|
2022
Q3 | $4.48M | Sell |
33,408
-537
| -2% | -$77.1K | 0.14% | 147 |
|
|
2022
Q2 | $5.2M | Buy |
33,945
+546
| +2% | +$83.4K | 0.16% | 133 |
|
|
2022
Q1 | $5.41M | Buy |
33,399
+4,047
| +14% | +$588K | 0.17% | 118 |
|
|
2021
Q4 | $3.97M | Buy |
29,352
+1,652
| +6% | +$195K | 0.12% | 152 |
|
|
2021
Q3 | $2.99M | Buy |
27,700
+10,150
| +58% | +$1.16M | 0.1% | 182 |
|
|
2021
Q2 | $1.98M | Buy |
17,550
+1,569
| +10% | +$177K | 0.07% | 222 |
|
|
2021
Q1 | $1.73M | Buy |
15,981
+4,697
| +42% | +$502K | 0.07% | 208 |
|
|
2020
Q4 | $1.21M | Buy |
11,284
+360
| +3% | +$34.6K | 0.06% | 219 |
|
|
2020
Q3 | $957K | Buy |
10,924
+2,704
| +33% | +$255K | 0.06% | 224 |
|
|
2020
Q2 | $807K | Buy |
8,220
+644
| +9% | +$56.7K | 0.06% | 203 |
|
|
2020
Q1 | $577K | Buy |
7,576
+1,730
| +30% | +$147K | 0.05% | 206 |
|
|
2019
Q4 | $518K | Buy |
5,846
+944
| +19% | +$78.4K | 0.04% | 263 |
|
|
2019
Q3 | $371K | Sell |
4,902
-1,138
| -19% | -$78K | 0.04% | 257 |
|
|
2019
Q2 | $431K | Sell |
6,040
-16
| -0.3% | -$1.26K | 0.06% | 203 |
|
|
2019
Q1 | $488K | Buy |
6,056
+671
| +12% | +$54.9K | 0.08% | 167 |
|
|
2018
Q4 | $496K | Buy |
5,385
+1,495
| +38% | +$131K | 0.13% | 125 |
|
|
2018
Q3 | $370K | Sell |
3,890
-1,046
| -21% | -$99.2K | 0.11% | 146 |
|
|
2018
Q2 | $460K | Sell |
4,936
-160
| -3% | -$15.6K | 0.16% | 119 |
|
|
2018
Q1 | $466K | Sell |
5,096
-458
| -8% | -$50.3K | 0.19% | 101 |
|
|
2017
Q4 | $553K | Buy |
+5,554
| New | +$523K | 0.24% | 83 |
|
Other funds holding ABBV
Integrated Wealth Concepts's ABBV Position: Q2 2026 in Review
Integrated Wealth Concepts increased its AbbVie (ABBV) stake by 27% in Q2 2026, buying an estimated $3.66M and bringing the position to 78,969 shares worth $19.9M. The position accounts for 0.1% of the portfolio, ranked #200.
Integrated Wealth Concepts first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Integrated Wealth Concepts held 78,969 shares of AbbVie worth $19.9M as of Q2 2026.
- Integrated Wealth Concepts bought 17,021 AbbVie shares in Q2 2026, an estimated $3.66M.
- AbbVie made up 0.1% of Integrated Wealth Concepts's portfolio in Q2 2026, its #200 holding.
- Integrated Wealth Concepts first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.